ALPS Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
+64,392
| New | +$2.13M | 0.01% | 359 |
|
|
2023
Q2 | – | Sell |
-62,694
| Closed | -$2.21M | – | 1011 |
|
|
2023
Q1 | $2.21M | Sell |
62,694
-1,433
| -2% | -$50.4K | 0.02% | 268 |
|
|
2022
Q4 | $2.94M | Buy |
64,127
+12,727
| +25% | +$583K | 0.03% | 235 |
|
|
2022
Q3 | $2.49M | Buy |
51,400
+588
| +1% | +$28.5K | 0.02% | 265 |
|
|
2022
Q2 | $2M | Sell |
50,812
-35,396
| -41% | -$1.39M | 0.02% | 320 |
|
|
2022
Q1 | $3.17M | Sell |
86,208
-10,863
| -11% | -$400K | 0.03% | 158 |
|
|
2021
Q4 | $4.42M | Sell |
97,071
-5,283
| -5% | -$241K | 0.05% | 157 |
|
|
2021
Q3 | $3.66M | Buy |
102,354
+7,862
| +8% | +$281K | 0.04% | 195 |
|
|
2021
Q2 | $1.87M | Sell |
94,492
-34,160
| -27% | -$676K | 0.02% | 335 |
|
|
2021
Q1 | $2.99M | Buy |
128,652
+1,214
| +1% | +$28.2K | 0.03% | 217 |
|
|
2020
Q4 | $2.65M | Buy |
+127,438
| New | +$2.65M | 0.03% | 232 |
|